If I understand what they are planning for multi myeloma, they will be adding a cannabis based drug they've developed to SOC drugs already in use. The price of the trials won't be cheap, but hopefully they will be supported by earnings from the psoriasis cream and perhaps others that don't require full efficacy testing.
If the psoriasis cream needed full FDA approved Phase 3 trials, it's cost would be dramatically higher and take years longer.